Select Medical (NYSE:SEM) Upgraded by Wall Street Zen to “Buy” Rating

Wall Street Zen upgraded shares of Select Medical (NYSE:SEM) from a hold rating to a buy rating in a research note released on Saturday morning.

A number of other research analysts have also issued reports on SEM. Weiss Ratings reiterated a “sell (d+)” rating on shares of Select Medical in a report on Wednesday, October 8th. Bank of America decreased their price objective on Select Medical from $18.00 to $15.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. UBS Group restated a “neutral” rating and set a $14.00 target price (down from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Benchmark reiterated a “buy” rating on shares of Select Medical in a research note on Monday, October 27th. Finally, Royal Bank Of Canada boosted their price target on shares of Select Medical from $16.00 to $20.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Select Medical presently has a consensus rating of “Moderate Buy” and a consensus target price of $17.80.

Select Medical Stock Down 0.1%

Shares of NYSE SEM traded down $0.02 during midday trading on Friday, hitting $13.30. The company’s stock had a trading volume of 1,061,476 shares, compared to its average volume of 1,140,292. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.15 and a quick ratio of 1.15. The firm has a market capitalization of $1.65 billion, a price-to-earnings ratio of 12.55, a price-to-earnings-growth ratio of 0.57 and a beta of 1.30. The business’s fifty day simple moving average is $13.20 and its two-hundred day simple moving average is $14.10. Select Medical has a 1 year low of $11.65 and a 1 year high of $40.98.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, October 30th. The health services provider reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.33 billion. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.43 EPS. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. On average, equities analysts predict that Select Medical will post 1.17 EPS for the current year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 25th. Shareholders of record on Wednesday, November 12th will be given a dividend of $0.0625 per share. The ex-dividend date of this dividend is Wednesday, November 12th. This represents a $0.25 annualized dividend and a yield of 1.9%. Select Medical’s payout ratio is 29.07%.

Hedge Funds Weigh In On Select Medical

Hedge funds have recently modified their holdings of the business. Price T Rowe Associates Inc. MD raised its position in Select Medical by 1.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,755,298 shares of the health services provider’s stock valued at $296,515,000 after purchasing an additional 270,488 shares during the last quarter. Vanguard Group Inc. increased its stake in Select Medical by 4.7% in the first quarter. Vanguard Group Inc. now owns 13,316,069 shares of the health services provider’s stock valued at $222,378,000 after purchasing an additional 603,079 shares during the period. State Street Corp boosted its stake in shares of Select Medical by 1.3% during the second quarter. State Street Corp now owns 4,253,793 shares of the health services provider’s stock worth $64,573,000 after buying an additional 55,686 shares during the period. Geode Capital Management LLC grew its holdings in shares of Select Medical by 2.7% during the second quarter. Geode Capital Management LLC now owns 3,035,186 shares of the health services provider’s stock worth $46,079,000 after buying an additional 80,425 shares during the last quarter. Finally, 8 Knots Management LLC acquired a new position in Select Medical in the 2nd quarter valued at about $26,568,000. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.